Advanced search
Publication Cover
Diabetes, Metabolic Syndrome and Obesity Volume 16, 2023 - Issue
Submit an article Journal homepage
152
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Potential Role and Expression Level of Urinary CXCL8 in Different Stages of Incipient Diabetic Nephropathy with Undiminished Creatinine Clearance: A Pilot Study

Yang He1 Hemodialysis Room, The First Hospital of Qinhuangdao, Qinhuangdao, 066000, People’s Republic of ChinaView further author information
,
Huili Li2 Department of Endocrinology, The First Hospital of Qinhuangdao Affiliated to Hebei Medical University, Qinhuangdao, 066000, People’s Republic of ChinaView further author information
,
Rui Wang3 Department of Endocrinology, The First Hospital of Qinhuangdao, Qinhuangdao, 066000, People’s Republic of ChinaView further author information
,
Ning Ma3 Department of Endocrinology, The First Hospital of Qinhuangdao, Qinhuangdao, 066000, People’s Republic of ChinaView further author information
,
Lianyuan Liu4 Functional Examination Department, The First Hospital of Qinhuangdao, Qinhuangdao, 066000, People’s Republic of ChinaView further author information
,
Rui Shi5 Rheumatology and Immunology Department, The First Hospital of Qinhuangdao, Qinhuangdao, 066000, People’s Republic of ChinaView further author information
,
Bohua Zhang3 Department of Endocrinology, The First Hospital of Qinhuangdao, Qinhuangdao, 066000, People’s Republic of ChinaView further author information
,
Ningning Lin6 Department of Dermatology, The First Hospital of Qinhuangdao, Qinhuangdao, 066000, People’s Republic of ChinaView further author information
&
Yiming Tian3 Department of Endocrinology, The First Hospital of Qinhuangdao, Qinhuangdao, 066000, People’s Republic of ChinaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-6162-0671View further author information
ORCID Icon show all
Pages 1783-1790 | Received 05 Mar 2023, Accepted 03 Jun 2023, Published online: 17 Jun 2023

References

  • American Diabetes Association. Standards of medical care in diabetes-2020. Diabetes Care. 2020;43:S1–S224.
  • Gülümsek E, Keşkek Ş. Direct medical cost of nephropathy in patients with type 2 diabetes. Int Urol Nephrol. 2022;54(6):1383–1389. doi:10.1007/s11255-021-03012-4
  • Sagoo MK, Gnudi L. Diabetic nephropathy: an overview. Methods Mol Biol. 2020;2067:3–7. doi:10.1007/978-1-4939-9841-8_1
  • Thakur V, Chattopadhyay M. Early urinary markers for diabetic and other kidney diseases. Curr Drug Targets. 2018;19(7):825–831. doi:10.2174/1389450119666180319124639
  • Milas O, Gadalean F, Vlad A, et al. Pro-inflammatory cytokines are associated with podocyte damage and proximal tubular dysfunction in the early stage of diabetic kidney disease in type 2 diabetes mellitus patients. J Diabetes Complications. 2020;34(2):107479. doi:10.1016/j.jdiacomp.2019.107479
  • Pan X, Kaminga AC, Wen SW, et al. Chemokines in prediabetes and type 2 diabetes: a meta-analysis. Front Immunol. 2021;12:622438. doi:10.3389/fimmu.2021.622438
  • Loretelli C, Rocchio F, D’Addio F, et al. The IL-8-CXCR1/2 axis contributes to diabetic kidney disease. Metabolism. 2021;121:154804. doi:10.1016/j.metabol.2021.154804
  • Yiming T, Tao L, Rui W, et al. Clinical prediction models based on neutrophil to lymphocyte ratio for diabetic nephropathies in middle aged and older patients with type 2 diabetes mellitus. Int J Geriatr. 2022;43(6):714–719. doi:10.3969/j.issn.1674-7593.2022.06.016
  • Higurashi M, Ohya Y, Joh K, et al. Increased urinary levels of CXCL5, CXCL8 and CXCL9 in patients with type 2 diabetic nephropathy. J Diabetes Complications. 2009;23(3):178–184. doi:10.1016/j.jdiacomp.2007.12.001
  • Verhave JC, Bouchard J, Goupil R, et al. Clinical value of inflammatory urinary biomarkers in overt diabetic nephropathy: a prospective study. Diabetes Res Clin Pract. 2013;101(3):333–340. doi:10.1016/j.diabres.2013.07.006
  • Liu SY, Chen J, Li YF. Clinical significance of serum interleukin-8 and soluble tumor necrosis factor-like weak inducer of apoptosis levels in patients with diabetic nephropathy. J Diabetes Investig. 2018;9(5):1182–1188. doi:10.1111/jdi.12828
  • Mogensen CE, Christensen CK, Vittinghus E. The stages in diabetic renal disease. With emphasis on the stage of incipient diabetic nephropathy. Diabetes. 1983;32(Suppl 2):64–78. doi:10.2337/diab.32.2.s64
  • Premaratne E, Verma S, Ekinci EI, et al. The impact of hyperfiltration on the diabetic kidney. Diabetes Metab. 2015;41(1):5–17. doi:10.1016/j.diabet.2014.10.003
  • Yoshida Y, Kashiwabara K, Hirakawa Y, et al. Conditions, pathogenesis, and progression of diabetic kidney disease and early decliner in Japan. BMJ Open Diabetes Res Care. 2020;8(1):e000902. doi:10.1136/bmjdrc-2019-000902
  • Levey AS, Bosch JP, Lewis JB, et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of diet in renal disease study group. Ann Intern Med. 1999;130(6):461–470. doi:10.7326/0003-4819-130-6-199903160-00002
  • Chow SC, Shao J, Wang H. Sample Size Calculations in Clinical Research. 2nd ed. Chapman & Hall/CRC Biostatistics Series; 2008.
  • Cui S, Qiao L, Yu S, et al. The antagonist of CXCR1 and CXCR2 protects db/db mice from metabolic diseases through modulating inflammation. Am J Physiol Endocrinol Metab. 2019;317(6):E1205–E1217. doi:10.1152/ajpendo.00117.2019
  • Zeng XF, Lu DX, Li JM, et al. Performance of urinary neutrophil gelatinase-associated lipocalin, clusterin, and cystatin C in predicting diabetic kidney disease and diabetic microalbuminuria: a consecutive cohort study. BMC Nephrol. 2017;18(1):233. doi:10.1186/s12882-017-0620-8

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.